NEWS
Tags: 

Commonwealth Informatics announces two-year collaboration with the FDA

Commonwealth Informatics, a provider of cloud-based clinical and safety analytics products and services, has signed a two-year Research Collaboration Agreement (RCA) with the US Food and Drug Administration (FDA).

The focus of the agreement is to enhance the Commonwealth Clinical Data Analytics (CCDA) platform for analysing drug safety data. CCDA is a flexible clinical data analytics platform used by healthcare and medical product researchers to access, transform, explore and analyse multiple data sources. It is anticipated that the enhanced CCDA software resulting from this research collaboration will help improve the speed and quality of data reviews, as well as enable critical analysis of complex drug safety data.

‘The Commonwealth team includes clinical and safety data experts who have developed several widely-used pharmacovigilance, clinical research, and healthcare data analysis systems,’ said Geoffrey Gordon, Commonwealth Informatics president. ‘CCDA is a breakthrough technology that empowers scientific and clinical decision makers to rapidly absorb and explore multiple types of relevant data sources. I look forward to this unique opportunity to collaborate closely with the FDA to enhance CCDA to meet FDA’s evolving needs.’

Under the RCA, FDA will provide expert scientific, clinical and statistical input to guide the further enhancement of CCDA to support FDA reviewers in rapidly detecting and investigating safety signals during new drug application (NDA) reviews and post-market pharmacovigilance activities. CCDA can potentially be used to improve the speed, quality, and transparency of analysing complex drug safety data to support regulatory decision-making.

Typically, clinical data analysis is carried out by several individuals with specialised knowledge and skills across multiple functional areas. Medical officers and safety reviewers need the ability to easily interact directly with the data and inspect and verify the intermediate analytical steps taken to generate final results. However, because of the complexity of the data, time and rework are often added to the process.

CCDA can dramatically improve the clinical data analysis process by enabling clinicians and analysts to work together more collaboratively and seamlessly to find the right answers to complex questions. It has an intuitive graphical user interface that allows users to work with diverse data sources via a simple, reproducible, step-by-step visual process, and this enables sophisticated data preparation and analysis without traditional programming. CCDA was developed in part through contracts sponsored by the Defense Health Program and the Army Pharmacovigilance Center.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Building a Smart Laboratory 2018 highlights the importance of adopting smart laboratory technology, as well as pointing out the challenges and pitfalls of the process

Feature

Informatics experts share their experiences on the implementing new technologies and manging change in the modern laboratory

Feature

This chapter will consider the different classes of instruments and computerised instrument systems to be found in laboratories and the role they play in computerised experiments and sample processing – and the steady progress towards all-electronic laboratories.

Feature

This chapter considers how the smart laboratory contributes to the requirements of a knowledge eco-system, and the practical consequences of joined-up science. Knowledge management describes the processes that bring people and information together to address the acquisition, processing, storage, use, and re-use of knowledge to develop understanding and to create value

Feature

This chapter takes the theme of knowledge management beyond document handling into the analysis and mining of data. Technology by itself is not enough – laboratory staff need to understand the output from the data analysis tools – and so data analytics must be considered holistically, starting with the design of the experiment